Ovarian carcinoma in situ with germline BRCA1 mutation and loss of heterozygosity at BRCA1 and TP53.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Journal of the National Cancer Institute

• Publication date

  2000-07-05

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1093/JNCI/92.13.1088PMID 10880552
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Increased frequency of TP53 mutations in BRCA1 and BRCA2 ovarian tumours

  1999cited by this paper
• Mutation analysis of BRCA1, TP53, and KRAS2 in ovarian and related pelvic tumors.

  1999cited by this paper
• Molecular genetic characterization of BRCA1- and BRCA2-linked hereditary ovarian cancers.

  1998cited by this paper
• Correlation of TP53 mutations and p53 expression in ovarian tumors.

  1998cited by this paper
• Mutational Analysis of BRCA1 Gene in Ovarian and Breast‐ovarian Cancer Families in Japan

  1997cited by this paper
• Reduced expression of retinoblastoma gene product (pRB) and high expression of p53 are associated with poor prognosis in ovarian cancer

  1997cited by this paper
• TP53 protein accumulation and gene mutation in relation to overexpression of MDM2 protein in ovarian borderline tumours and stage I carcinomas

  1997cited by this paper
• p53 allelotypes and enhanced detection of allelic loss in ovarian cancer: lack of correlation with familial and clinical factors.

  1996cited by this paper
• Mutation analysis of the BRCA1 gene in ovarian cancers.

  1995cited by this paper
• Mutation analysis of the BRCA1 gene in 76 Japanese ovarian cancer patients: four germline mutations, but no evidence of somatic mutation.

  1995cited by this paper
• Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium.

  1995cited by this paper
• Germline mutations of the BRCA1 gene in breast and ovarian cancer families provide evidence for a genotype–phenotype correlation

  1995cited by this paper
• P53 mutation in a series of epithelial ovarian cancers from the U.K., and its prognostic significance.

  1994cited by this paper
• p53 expression in ovarian borderline tumors and stage I carcinomas.

  1994cited by this paper
• Alteration of p53 gene in ovarian carcinoma: clinicopathological correlation and prognostic significance.

  1994cited by this paper
• Early de novo ovarian carcinoma. A study of fourteen cases

  1994cited by this paper
• BRCA1 mutations in primary breast and ovarian carcinomas.

  1994cited by this paper
• Prognostic significance of p53 immunostaining in epithelial ovarian cancer.

  1994cited by this paper
• Mutations in the BRCA1 gene in families with early-onset breast and ovarian cancer

  1994cited by this paper
• p53 gene mutations and protein accumulation in human ovarian cancer.

  1993cited by this paper
• Mutation and overexpression of p53 in early-stage epithelial ovarian cancer.

  1993cited by this paper
• The tumor suppressor genes.

  1993cited by this paper
• Spectrum of mutation and frequency of allelic deletion of the p53 gene in ovarian cancer.

  1993cited by this paper
• Tumor suppressor genes.

  1991cited by this paper
• Mutation and cancer: statistical study of retinoblastoma.

  1971cited by this paper

• Pathogenesis of peritoneal high‐grade serous carcinoma after risk‐reducing surgery: a systematic review

  2025cites this paper
• A BRCA1 Splice Site Variant Responsible for Familial Ovarian Cancer in a Han-Chinese Family

  2022cites this paper
• Comprehensive Study of Germline Mutations and Double-Hit Events in Esophageal Squamous Cell Cancer

  2021influential citation
• Mechanisms of High-Grade Serous Carcinogenesis in the Fallopian Tube and Ovary: Current Hypotheses, Etiologic Factors, and Molecular Alterations

  2021cites this paper
• Clinical significance of β-catenin, hTERT, p53, and Wnt7A as biomarkers for ovarian cancer

  2020cites this paper
• A comprehensive DNA panel next generation sequencing approach supporting diagnostics and therapy prediction in neurooncology

  2020cites this paper
• Inferring Novel Tumor Suppressor Genes with a Protein-Protein Interaction Network and Network Diffusion Algorithms

  2018cites this paper
• Cancer Vaccines for HPV Malignancies

  2018cites this paper
• Prognosis of patients with BRCA1-associated ovarian carcinomas depends on TP53 accumulation status in tumor cells.

  2017cites this paper
• Müllerian intra-abdominal carcinomatosis in hereditary breast ovarian cancer syndrome: implications for risk-reducing surgery

  2016cites this paper
• 14 P 53 Network in Ovarian Cancer

  2014cites this paper
• BRCA 1/2-Mutation Related and Sporadic Breast and Ovarian Cancers: More Alike than Different

  2014cites this paper
• The origin of ovarian cancers--hypotheses and controversies.

  2013cites this paper
• Ovarian cancer as a genetic disease.

  2013influential citation
• Identification of somatic mutations in cancer through Bayesian-based analysis of sequenced genome pairs

  2013cites this paper
• Identification of somatic mutations in cancer through Bayesian-based analysis of sequenced genome pairs

  2013cites this paper
• Impact of lifestyle factors on preneoplastic changes in prophylactic oophorectomies of BRCA mutation carriers

  2012cites this paper
• P53 Network in Ovarian Cancer

  2012cites this paper
• Ovarian serous carcinoma: recent concepts on its origin and carcinogenesis

  2012influential citation
• High frequency of allelic loss at the BRCA1 locus in ovarian cancers: clinicopathologic and molecular associations.

  2012cites this paper
• The ovary feels fine when paracrine and autocrine networks cooperate with gonadotropins in the regulation of folliculogenesis.

  2012cites this paper
• The application of laparoscopy in abdominal trauma at Al-Jumhoori Teaching Hospital in Mosul

  2012cites this paper
• P53 expression in ovarian tumors: (an immunohistochemical study)

  2012cites this paper
• The mutational profile of sporadic epithelial ovarian carcinoma.

  2011cites this paper
• Expression of Xeroderma Pigmentosum Group G (XPG) in Sporadic Breast Carcinoma

  2010cites this paper
• Genetic Analysis of the Early Natural History of Epithelial Ovarian Carcinoma

  2010cites this paper
• Characterization and Comparison of Precursors of Ovarian and Endometrial Carcinoma: Parts I and II

  2010cites this paper
• Ovarian Low-grade and High-grade Serous Carcinoma: Pathogenesis, Clinicopathologic and Molecular Biologic Features, and Diagnostic Problems

  2009cites this paper
• Precursors of endometrial and ovarian carcinoma

  2009cites this paper
• The mammalian ovary from genesis to revelation.

  2009cites this paper
• Dysplasie épithéliale ovarienne : mythe ou réalité ? Revue de la littérature

  2008cites this paper
• Role of p53 and Rb in ovarian cancer.

  2008cites this paper
• [Ovarian epithelial dysplasia: myth or reality? Review].

  2008cites this paper
• Loss of heterozygosity of the PTH/PTHrP type 1 receptor in oral squamous cell carcinoma.

  2008cites this paper
• Whence epithelial ovarian carcinoma?

  2008cites this paper
• Sporadic epithelial ovarian cancer: clinical relevance of BRCA1 inhibition in the DNA damage and repair pathway.

  2008cites this paper
• The distal fallopian tube: a new model for pelvic serous carcinogenesis

  2007cites this paper
• BRCA1 and p53 protein expression in cultured ovarian surface epithelial cells derived from women with and without a BRCA1 germline mutation

  2006cites this paper
• A mouse model for the molecular characterization of brca1-associated ovarian carcinoma.

  2006cites this paper
• Histochemical Technologies for Genomics and Proteomics : Laser Capture Microdissection (LCM) and Tissue Microarray (TMA)( Tokyo Satellite Symposium "Contribution of Histochemistry in Basic Science and Clinical Medicine")

  2005cites this paper
• Origins and molecular pathology of ovarian cancer

  2005cites this paper
• Cultures of ovarian surface epithelium from women with and without a hereditary predisposition to develop female adnexal carcinoma.

  2004cites this paper
• Loss of heterozygosity at BRCA2 in a ductal carcinoma in situ and three invasive breast carcinomas in a family with a germline BRCA2 mutation

  2004cites this paper
• Familial association of specific histologic types of ovarian malignancy with other malignancies

  2004cites this paper
• Familial clustering of ovarian and endometrial cancers.

  2004cites this paper
• A fluid cover medium provides superior morphology and preserves RNA integrity in tissue sections for laser microdissection and pressure catapulting

  2004cites this paper
• Expression of BRCA1 protein in benign, borderline, and malignant epithelial ovarian neoplasms and its relationship to methylation and allelic loss of the BRCA1 gene

  2004cites this paper
• Chemosensitivity and radiosensitivity profiles of four new human epithelial ovarian cancer cell lines exhibiting genetic alterations in BRCA2, TGFβ-RII, KRAS2, TP53 and/or CDNK2A

  2004cites this paper
• Intraperitoneal serous adenocarcinoma: a critical appraisal of three hypotheses on its cause.

  2004cites this paper
• Histopathology, FIGO Stage, and BRCA Mutation Status of Ovarian Cancers from the Gilda Radner Familial Ovarian Cancer Registry

  2004cites this paper
• Chapter 62 – Hereditary Gynecologic Cancer Syndromes

  2004cites this paper
• Hereditary serous ovarian carcinogenesis, a hypothesis

  2004cites this paper
• Speculation and Deductive Reasoning About Ovarian Epithelial Carcinogenesis and New Horizons

  2003cites this paper
• Early Diagnosis and Screening for Ovarian Cancer

  2003cites this paper
• Prognostic significance of the allelic loss of the BRCA1 gene in colorectal cancer

  2003cites this paper
• High epithelial and stromal genetic instability of chromosome 17 in ulcerative colitis-associated carcinogenesis.

  2003cites this paper
• Advances in Brief High Epithelial and Stromal Genetic Instability of Chromosome 17 in Ulcerative Colitis-associated Carcinogenesis 1

  2003cites this paper
• Familial invasive and borderline ovarian tumors by proband status, age and histology

  2003cites this paper
• Familial risk of cancer by site and histopathology

  2003cites this paper
• Approaches to proteomic analysis of human tumors.

  2003cites this paper
• Prophylactic oophorectomy

  2003cites this paper
• Frequent LOH at hMLH1, a highly variable SNP in hMSH3, and negligible coding instability in ovarian cancer.

  2002cites this paper
• Genetic alterations related to lymph node metastasis and peritoneal dissemination in epithelial ovarian cancers.

  2002cites this paper
• Current understanding of the epidemiology and clinical implications of BRCA1 and BRCA2 mutations for ovarian cancer

  2002cites this paper
• Dysplastic changes in prophylactically removed Fallopian tubes of women predisposed to developing ovarian cancer

  2001cites this paper
• Allelic imbalance and microsatellite instability in BRCA1 associated breast and ovarian tumors.

  2001cites this paper
• Loss of heterozygosity of nucleotide excision repair factors in sporadic ovarian, colon and lung carcinomas: implication for their roles of carcinogenesis in human solid tumors.

  2001cites this paper
• Loss of heterozygosity of nucleotide excision repair factors in sporadic oral squamous cell carcinoma using microdissected tissue.

  2001cites this paper
• [Molecular abnormalities in epithelial ovarian tumors: present and future].

  2001cites this paper
• Histopathology of familial ovarian tumors in women from families with and without germline BRCA1 mutations.

  2000cites this paper